NCT00003598View on ClinicalTrials.gov

UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

March 31, 2001

Study Completion Date

November 30, 2009

Conditions
Cervical CancerPrecancerous/Nonmalignant Condition
Interventions
DRUG

tretinoin

Trial Locations (1)

48109-0752

University of Michigan Comprehensive Cancer Center, Ann Arbor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Michigan Rogel Cancer Center

OTHER

NCT00003598 - UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia | Biotech Hunter | Biotech Hunter